2003 Healthcare Pharma 
Eversana Intouch
NOVEMBER 9, 2023
Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. These data are astonishing, given the perception that Big Pharma is the main driver of biopharma innovation. Yet, we know small-to-mid-sized pharma launches face a unique set of challenges.
Healthcare Success
OCTOBER 17, 2024
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 9, 2022
The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. However, what is clearer still is that vulnerable groups need support and healthcare systems need to adapt to become stronger and more resistant.
Silver Line CRM
SEPTEMBER 24, 2020
Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training. As a leader in this market, VMS seeks constant improvement to their patient and healthcare provider experiences.
pharmaphorum
DECEMBER 6, 2022
A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. This is the way in which the UK’s Our Future Health research programme aims to provide a breakthrough in healthcare and medicine. Aims for the project.
pharmaphorum
DECEMBER 22, 2022
Bingham replied that pharma, biotech, and academia all need to come up with new approaches. However, she continued, pharma generally doesn’t voluntarily go down such a route. There were screening recommendations back in 2003 and they have yet to be fully implemented. These, after all, are expensive, she said.
Clarivate
OCTOBER 17, 2024
Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. In public speeches, she has suggested possibly expanding the program beyond Medicare, presumably to the commercial insurance market (covering 47% of all lives in the U.S.).
Expert insights. Personalized for you.
105 
Let's personalize your content